Work

Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

Year: 2014
Type: article
Abstract: Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
Source: PubMed
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W1566174797
FWCI: 1.909
Cites: 15
Cited by: 80
Related to: 10